Mark R. Ziebell - 18 Mar 2022 Form 4 Insider Report for Avid Bioservices, Inc.

Role
V. P., General Counsel
Signature
/s/ Mark R. Ziebell
Issuer symbol
N/A
Transactions as of
18 Mar 2022
Net transactions value
-$120,441
Form type
4
Filing time
22 Mar 2022, 19:50:07 UTC
Previous filing
11 Feb 2022
Next filing
12 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise $4,284 +1,302 +17% $3.29 9,077 18 Mar 2022 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale $28,660 -1,302 -14% $22.01 7,775 18 Mar 2022 Direct F1, F2
transaction CDMO Common Stock, $0.001 par value Options Exercise $6,494 +1,974 +25% $3.29 9,749 21 Mar 2022 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale $43,482 -1,974 -20% $22.03 7,775 21 Mar 2022 Direct F1, F3
transaction CDMO Common Stock, $0.001 par value Options Exercise $10,370 +3,152 +41% $3.29 10,927 22 Mar 2022 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale $69,447 -3,152 -29% $22.03 7,775 22 Mar 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Stock Option (right to buy) Options Exercise $0 -1,302 -0.5% $0.000000 257,882 18 Mar 2022 Common Stock 1,302 $3.29 Direct F1, F4
transaction CDMO Stock Option (right to buy) Options Exercise $0 -1,974 -0.77% $0.000000 255,908 21 Mar 2022 Common Stock 1,974 $3.29 Direct F1, F4
transaction CDMO Stock Option (right to buy) Options Exercise $0 -3,152 -1.2% $0.000000 252,756 22 Mar 2022 Common Stock 3,152 $3.29 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 14, 2021.
F2 Represents a weighted average sales price per share. These shares were sold at prices ranging from $22.00 to $22.06. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Represents a weighted average sales price per share. These shares were sold at prices ranging from $22.00 to $22.09. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 Stock option granted to the reporting person on June 20, 2012 vested quarterly over a three (3) year period and was fully vested as of June 20, 2015.